{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:17:43Z","timestamp":1793852263028,"version":"4.6.1"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI136626"],"award-info":[{"award-number":["R01 AI136626"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F32 AI164809"],"award-info":[{"award-number":["F32 AI164809"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>It remains unclear if cure of hepatitis C virus (HCV) infection with direct-acting antivirals (DAAs) ameliorates HCV-related inflammation and bone deficits. We evaluated changes in cytokines and bone measurements by high-resolution peripheral quantitative computed tomography (HR-pQCT) prior to DAA treatment and 18 months following initiation and compared changes in uninfected controls over 18 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a cohort study of 40 participants who initiated DAAs and achieved cure and 48 without HCV as controls. At enrollment and 18 months later, participants had measurements of volumetric bone mineral density, cortical dimensions, and mechanical properties of the radius and tibia by HR-pQCT; visceral fat area and appendicular lean mass by whole-body dual-energy X-ray absorptiometry; and serum tumor necrosis factor alpha (TNF-\u03b1), interleukin 6 (IL-6), and interleukin 18 (IL-18). Multivariable linear regression was used to estimate group differences in mean changes in bone measurements and cytokines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We observed no significant differences in month 0\u201318 changes in HR-pQCT measurements between participants with cured HCV and controls in unadjusted models or after adjustment for age, sex, appendicular lean mass index, visceral fat area, and smoking. Participants with cured HCV had decreases in IL-18 (mean change, \u22120.085 vs +0.086 log pg\/mL; P &amp;lt; .001) and TNF-\u03b1 (mean change, \u22120.050 vs +0.084 log pg\/mL; P &amp;lt; .001), but not IL-6 (mean change, +0.108 vs +0.009 log pg\/mL; P = .214) versus controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Participants with cured HCV had no significant changes in bone microarchitecture by HR-pQCT 18 months after DAA initiation compared with controls, but did have decreases in IL-18 and TNF-\u03b1 versus controls.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf571","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T19:57:02Z","timestamp":1758311822000},"source":"Crossref","is-referenced-by-count":2,"title":["Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0600","authenticated-orcid":false,"suffix":"III","given":"Vincent","family":"Lo Re","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Center for Clinical Epidemiology and Biostatistics, Center for Real-world Effectiveness and Safety of Therapeutics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0310-270X","authenticated-orcid":false,"given":"Dean M","family":"Carbonari","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Center for Real-world Effectiveness and Safety of Therapeutics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W","family":"Newcomb","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Center for Real-world Effectiveness and Safety of Therapeutics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7861-1421","authenticated-orcid":false,"given":"Jessie","family":"Torgersen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Center for Clinical Epidemiology and Biostatistics, Center for Real-world Effectiveness and Safety of Therapeutics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-8962","authenticated-orcid":false,"given":"Erica J","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanae M","family":"Smith","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Center for Real-world Effectiveness and Safety of Therapeutics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L","family":"Brecker","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Center for Real-world Effectiveness and Safety of Therapeutics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-2232","authenticated-orcid":false,"given":"X Sherry","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Department of Bioengineering, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R","family":"Kostman","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Trooskin","sequence":"additional","affiliation":[{"name":"Mazzoni Center , Philadelphia, Pennsylvania \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-0994","authenticated-orcid":false,"given":"Rebecca A","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Brown University , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0799-7563","authenticated-orcid":false,"given":"Joshua F","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6164-7348","authenticated-orcid":false,"given":"Babette S","family":"Zemel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-6582","authenticated-orcid":false,"given":"Mary B","family":"Leonard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Medicine, Stanford University School of Medicine , Palo Alto, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2025092608465779800_ofaf571-B1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMra2033539","article-title":"Extrahepatic manifestations of chronic HCV infection","volume":"384","author":"Cacoub","year":"2021","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/jhep.2001.20533","article-title":"Hepatic osteodystrophy","volume":"33","author":"Rouillard","year":"2001","journal-title":"Hepatology"},{"key":"2025092608465779800_ofaf571-B3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"American Gastroenterological Association Clinical Practice Committee. AGA technical review on osteoporosis in hepatic disorders","volume":"125","author":"Leslie","year":"2003","journal-title":"Gastroenterology"},{"key":"2025092608465779800_ofaf571-B4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.trstmh.2010.01.012","article-title":"The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt","volume":"104","author":"Raslan","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025092608465779800_ofaf571-B5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-012-9653-y","article-title":"Association between chronic hepatitis C virus infection and bone mineral density","volume":"91","author":"Lin","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"2025092608465779800_ofaf571-B6","doi-asserted-by":"crossref","first-page":"e81652","DOI":"10.1371\/journal.pone.0081652","article-title":"Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C","volume":"8","author":"Orsini","year":"2013","journal-title":"PLoS One"},{"key":"2025092608465779800_ofaf571-B7","doi-asserted-by":"crossref","first-page":"e2086","DOI":"10.1097\/MD.0000000000002086","article-title":"Relation between hepatitis C virus exposure and risk of osteoporosis: a nationwide population-based study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025092608465779800_ofaf571-B8","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.25866","article-title":"Risk of hip fracture associated with hepatitis C virus infection and hepatitis C\/human immunodeficiency virus coinfection","volume":"56","author":"Lo Re","year":"2012","journal-title":"Hepatology"},{"key":"2025092608465779800_ofaf571-B9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2014.03.007","article-title":"Fracture risk in hepatitis C virus infected persons: results from the DANVIR cohort study","volume":"61","author":"Hansen","year":"2014","journal-title":"J Hepatol"},{"key":"2025092608465779800_ofaf571-B10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2025092608465779800_ofaf571-B11","first-page":"401","article-title":"Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis","volume":"8","author":"Kontulainen","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2025092608465779800_ofaf571-B12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jbmr.3901","article-title":"HR-pQCT measures of bone microarchitecture predict fracture: systematic review and meta-analysis","volume":"35","author":"Mikolajewicz","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B13","doi-asserted-by":"crossref","first-page":"ofaf102","DOI":"10.1093\/ofid\/ofaf102","article-title":"Abnormal trabecular and cortical bone microarchitecture in chronic hepatitis C infection and associations with select inflammatory cytokines","volume":"12","author":"Weinstein","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2025092608465779800_ofaf571-B14","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1023\/A:1018804426724","article-title":"Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection","volume":"42","author":"Nelson","year":"1997","journal-title":"Dig Dis Sci"},{"key":"2025092608465779800_ofaf571-B15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.trsl.2007.01.007","article-title":"Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection","volume":"150","author":"Chen","year":"2007","journal-title":"Transl Res"},{"issue":"1 Suppl","key":"2025092608465779800_ofaf571-B16","first-page":"e514","article-title":"Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis","volume":"128","author":"Sharma","year":"2009","journal-title":"Immunology"},{"key":"2025092608465779800_ofaf571-B17","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","article-title":"Hepatitis C virus induces interleukin-1beta (IL-1beta)\/IL-18 in circulatory and resident liver macrophages","volume":"87","author":"Shrivastava","year":"2013","journal-title":"J Virol"},{"key":"2025092608465779800_ofaf571-B18","doi-asserted-by":"crossref","first-page":"20045","DOI":"10.1038\/s41598-023-47335-x","article-title":"Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection","volume":"13","author":"Radkowski","year":"2023","journal-title":"Sci Rep"},{"key":"2025092608465779800_ofaf571-B19","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","article-title":"Inhibition of osteoblast differentiation by tumor necrosis factor-alpha","volume":"141","author":"Gilbert","year":"2000","journal-title":"Endocrinology"},{"key":"2025092608465779800_ofaf571-B20","doi-asserted-by":"crossref","first-page":"e0154677","DOI":"10.1371\/journal.pone.0154677","article-title":"IL-6 contributes to the defective osteogenesis of bone marrow stromal cells from the vertebral body of the glucocorticoid-induced osteoporotic mouse","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"2025092608465779800_ofaf571-B21","doi-asserted-by":"crossref","first-page":"33680","DOI":"10.1038\/srep33680","article-title":"IL-18BP is decreased in osteoporotic women: prevents inflammasome mediated IL-18 activation and reduces Th17 differentiation","volume":"6","author":"Mansoori","year":"2016","journal-title":"Sci Rep"},{"key":"2025092608465779800_ofaf571-B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41413-018-0040-9","article-title":"RANKL-RANK signaling regulates osteoblast differentiation and bone formation","volume":"6","author":"Cao","year":"2018","journal-title":"Bone Res"},{"key":"2025092608465779800_ofaf571-B23","doi-asserted-by":"crossref","first-page":"49343","DOI":"10.1074\/jbc.M103642200","article-title":"Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"2025092608465779800_ofaf571-B24","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3389\/fimmu.2019.02925","article-title":"TNF-alpha directly enhances osteocyte RANKL expression and promotes osteoclast formation","volume":"10","author":"Marahleh","year":"2019","journal-title":"Front Immunol"},{"key":"2025092608465779800_ofaf571-B25","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa1315722","article-title":"Treatment of HCV with ABT-450\/r-ombitasvir and dasabuvir with ribavirin","volume":"370","author":"Feld","year":"2014","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","article-title":"Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1","volume":"373","author":"Naggie","year":"2015","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B29","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jama.2015.1373","article-title":"Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection","volume":"313","author":"Osinusi","year":"2015","journal-title":"JAMA"},{"key":"2025092608465779800_ofaf571-B30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1056\/NEJMoa1503153","article-title":"Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1","volume":"373","author":"Wyles","year":"2015","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.2015.1328","article-title":"Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial","volume":"313","author":"Sulkowski","year":"2015","journal-title":"JAMA"},{"key":"2025092608465779800_ofaf571-B32","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"2025092608465779800_ofaf571-B33","author":"American Association for the Study of Liver Diseases and the Infectious Diseases Society of America"},{"key":"2025092608465779800_ofaf571-B34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025092608465779800_ofaf571-B35","first-page":"541","article-title":"Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges","volume":"31","author":"Shahnazarian","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"2025092608465779800_ofaf571-B36","doi-asserted-by":"crossref","first-page":"101785","DOI":"10.1016\/j.bonr.2024.101785","article-title":"Association between nonalcoholic fatty liver disease and bone mineral density: Mendelian randomization and mediation analysis","volume":"22","author":"Zheng","year":"2024","journal-title":"Bone Rep"},{"key":"2025092608465779800_ofaf571-B37","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2893.2008.01038.x","article-title":"Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy","volume":"15","author":"Hofmann","year":"2008","journal-title":"J Viral Hepat"},{"issue":"10","key":"2025092608465779800_ofaf571-B38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF02599279","article-title":"Screening with the Alcohol Use Disorders Identification Test (AUDIT) in an inner-city population","volume":"9","author":"Isaacson","year":"1994","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2025092608465779800_ofaf571-B39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The drug abuse screening test","volume":"7","author":"Skinner","year":"1982","journal-title":"Addict Behav"},{"key":"2025092608465779800_ofaf571-B40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based non-invasive liver disease assessments of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"key":"2025092608465779800_ofaf571-B41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1359\/jbmr.091104","article-title":"Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia","volume":"25","author":"Burghardt","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2818.1997.1340694.x","article-title":"A new method for the model-independent assessment of thickness in three-dimensional images","volume":"185","author":"Hildebrand","year":"1997","journal-title":"J Microsc"},{"key":"2025092608465779800_ofaf571-B43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","article-title":"Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus","volume":"14","author":"Hildebrand","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B44","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/jbmr.111","article-title":"Bone density, geometry, microstructure, and stiffness: relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women","volume":"25","author":"Liu","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B45","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jbmr.420","article-title":"Individual trabecula segmentation (ITS)-based morphological analysis of microscale images of human tibial trabecular bone at limited spatial resolution","volume":"26","author":"Liu","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jbmr.562","article-title":"Individual trabecula segmentation (ITS)-based morphological analyses and microfinite element analysis of HR-pQCT images discriminate postmenopausal fragility fractures independent of DXA measurements","volume":"27","author":"Liu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B47","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/jbmr.378","article-title":"Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women","volume":"26","author":"Liu","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B48","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.1919","article-title":"Fast trabecular bone strength predictions of HR-pQCT and individual trabeculae segmentation-based plate and rod finite element model discriminate postmenopausal vertebral fractures","volume":"28","author":"Liu","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B49","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy X-ray absorptiometry body composition reference values from NHANES","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS One"},{"key":"2025092608465779800_ofaf571-B50","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/jbmr.1666","article-title":"Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men","volume":"27","author":"Lebrasseur","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2012.11.035","article-title":"Associations between body composition and bone density and structure in men and women across the adult age spectrum","volume":"53","author":"Baker","year":"2013","journal-title":"Bone"},{"key":"2025092608465779800_ofaf571-B52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00223-010-9398-4","article-title":"Relationship between visceral adiposity and bone mineral density in Korean adults","volume":"87","author":"Choi","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"2025092608465779800_ofaf571-B53","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2013-1047","article-title":"Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study","volume":"98","author":"Cohen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025092608465779800_ofaf571-B54","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1210\/jc.2008-2422","article-title":"Reciprocal relations of subcutaneous and visceral fat to bone structure and strength","volume":"94","author":"Gilsanz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2025092608465779800_ofaf571-B55","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bone.2010.12.011","article-title":"Determinants of bone mineral density in obese premenopausal women","volume":"48","author":"Bredella","year":"2011","journal-title":"Bone"},{"key":"2025092608465779800_ofaf571-B56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1359\/jbmr.090807","article-title":"Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study","volume":"25","author":"Lang","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B57","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/jbmr.107","article-title":"Adipose tissue and volumetric bone mineral density of older Afro-Caribbean men","volume":"25","author":"Yerges-Armstrong","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B58","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00198-013-2322-9","article-title":"Abdominal body composition measured by quantitative computed tomography and risk of non-spine fractures: the Osteoporotic Fractures in Men (MrOS) study","volume":"24","author":"Sheu","year":"2013","journal-title":"Osteoporos Int"},{"key":"2025092608465779800_ofaf571-B59","doi-asserted-by":"crossref","first-page":"E1041","DOI":"10.1210\/jc.2013-1272","article-title":"Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females","volume":"98","author":"Deere","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025092608465779800_ofaf571-B60","first-page":"401","article-title":"Peripheral quantitative computed tomography-derived muscle density and peripheral magnetic resonance imaging-derived muscle adiposity: precision and associations with fragility fractures in women","volume":"14","author":"Wong","year":"2014","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2025092608465779800_ofaf571-B61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3945\/ajcn.113.081778","article-title":"Visceral adiposity is negatively associated with bone density and muscle attenuation","volume":"101","author":"Zhang","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"2025092608465779800_ofaf571-B62","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","article-title":"Mechanisms and metabolic implications of regional differences among fat depots","volume":"17","author":"Tchkonia","year":"2013","journal-title":"Cell Metab"},{"key":"2025092608465779800_ofaf571-B63","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2014an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2025092608465779800_ofaf571-B64","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/db11-0860","article-title":"Increased macrophage migration into adipose tissue in obese mice","volume":"61","author":"Oh","year":"2012","journal-title":"Diabetes"},{"key":"2025092608465779800_ofaf571-B65","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2337\/db06-0133","article-title":"Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity","volume":"55","author":"Cancello","year":"2006","journal-title":"Diabetes"},{"key":"2025092608465779800_ofaf571-B66","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.numecd.2008.12.016","article-title":"Macrophage infiltrates with high levels of Toll-like receptor 4 expression in white adipose tissues of male Chinese","volume":"19","author":"Zhang","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025092608465779800_ofaf571-B67","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-014-2663-z","article-title":"Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin","volume":"25","author":"Redondo-Cerezo","year":"2014","journal-title":"Osteoporos Int"},{"key":"2025092608465779800_ofaf571-B68","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12519-017-0013-x","article-title":"Pegylated interferon alpha\/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection","volume":"13","author":"Megahed","year":"2017","journal-title":"World J Pediatr"},{"key":"2025092608465779800_ofaf571-B69","doi-asserted-by":"crossref","first-page":"e2026","DOI":"10.1093\/cid\/ciaa1396","article-title":"Effects of hepatitis C virus (HCV) eradication on bone mineral density in human immunodeficiency virus\/HCV-coinfected patients","volume":"73","author":"Carrero","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025092608465779800_ofaf571-B70","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","article-title":"Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study","volume":"6","author":"Thayu","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025092608465779800_ofaf571-B71","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ibd.20149","article-title":"Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease","volume":"13","author":"Thayu","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2025092608465779800_ofaf571-B72","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1359\/jbmr.071205","article-title":"Genetic and environmental influence on structural strength of weight-bearing and non-weight-bearing bone: a twin study","volume":"23","author":"Mikkola","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jbmr.3288","article-title":"Effects of a randomized weight loss intervention trial in obese adolescents on tibia and radius bone geometry and volumetric density","volume":"33","author":"Kelley","year":"2018","journal-title":"J Bone Miner Res"},{"key":"2025092608465779800_ofaf571-B74","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/v14081613","article-title":"The effect of treatment-induced viral eradication on cytokine and growth factor expression in chronic hepatitis C","volume":"14","author":"Radmanic","year":"2022","journal-title":"Viruses"},{"key":"2025092608465779800_ofaf571-B75","doi-asserted-by":"crossref","first-page":"ofad623","DOI":"10.1093\/ofid\/ofad623","article-title":"Changes in inflammatory cytokines after chronic hepatitis C treatment among people living with HIV","volume":"11","author":"Karimi-Sari","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025092608465779800_ofaf571-B76","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ajg.2012.137","article-title":"Reduction in hepatic inflammation is associated with less fibrosis progression and fewer clinical outcomes in advanced hepatitis C","volume":"107","author":"Morishima","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2025092608465779800_ofaf571-B77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archinte.164.3.338-a","article-title":"Opioid osteoporosis","volume":"164","author":"Daniell","year":"2004","journal-title":"Arch Intern Med"},{"key":"2025092608465779800_ofaf571-B78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.afos.2023.09.001","article-title":"Illicit drug use is associated with lower bone mineral density and bone strength","volume":"9","author":"Krishnamoorthy","year":"2023","journal-title":"Osteoporos Sarcopenia"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf571\/64267396\/ofaf571.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/9\/ofaf571\/64267396\/ofaf571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/9\/ofaf571\/64267396\/ofaf571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:47:15Z","timestamp":1758890835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf571\/8253981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":78,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf571","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,29]]},"article-number":"ofaf571"}}